Functionalized DNA nanoplatform for multi-target simultaneous imaging: Establish the atlas of cancer cell species

Xuan Zhao1, Na Na1, Jin Ouyang2

  • 1College of Chemistry, Beijing Normal University, Beijing, 100875, China.

Talanta
|October 1, 2023
PubMed

Insights

This study introduces a novel logic gate DNA nano-platform (LGDP) for precise, single-molecule imaging of cell membrane proteins. This technology enables synergistic cancer cell diagnosis, improving early detection and treatment strategies.

Area of Science:

  • Biotechnology
  • Molecular Imaging
  • Cancer Diagnostics

Background:

  • Accurate detection of cell membrane proteins is crucial for cancer diagnosis.
  • Single biomarker recognition can lead to false positives and off-target effects.
  • Existing nucleic acid probes may cause non-specific cell internalization.

Purpose of the Study:

  • To develop a logic gate DNA nano-platform (LGDP) for synergistic diagnosis of cancer cells.
  • To enable single-molecule imaging and precise discrimination of different cell lines.
  • To improve the accuracy and efficiency of cancer cell analysis.

Main Methods:

  • Construction of a logic gate DNA nano-platform (LGDP).
  • Utilizing aptamer-functionalized molecular machines for logic-gated recognition.
  • Integration with single-molecule technology for qualitative and quantitative analysis.

Main Results:

  • LGDP demonstrated a traffic light-like color response for precise cell line discrimination.
  • Synergistic qualitative and quantitative analysis of target proteins was achieved.
  • The platform facilitated accurate identification of cancer cells.

Conclusions:

  • The developed LGDP offers a novel approach for single-molecule imaging of cell membrane proteins.
  • Logic-gated recognition enhances the accuracy and speed of cancer cell analysis.
  • This technology lays the foundation for early cancer diagnosis and treatment.

Related Concept Videos